跳至主要内容
临床试验/NCT04366947
NCT04366947已完成不适用

Comparison of Intraosseous Versus Intravenous Access in Suspected/Confirmed COVID-19 Patient in Prehospital Setting

Lazarski University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年4月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
Success rate of first intravascular access attempt

研究概览

简要总结

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Out-of-hospital cardiac arrest (OHCA)
  • Adult ≥ 18 years old
  • Non-traumatic cause of cardiac arrest

排除标准

  • Existing do-not-attempt-resuscitation order
  • OHCA patients with contraindications to IO access or IV access
  • Patients with signs of obvious death, e.g. rigor mortis

结局指标

主要结局

Success rate of first intravascular access attempt

时间窗: 1 day

successful placement of intravascular device

次要结局

  • complication rates(1 day)
  • number of attempts to successful access(1 day)
  • time to infusion(1 day)
  • ROSC(1 day)
  • time to successful access(1 day)

研究者

发起方
Lazarski University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lukasz Szarpak

Assoc Prof PhD

Lazarski University

研究点 (2)

Loading locations...

相似试验